ClinicalTrials.gg

Program

Cetylpyridinium

Also written as “Cetylpyridinium chloride”, “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash” and “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”.

Its studies are mostly in Gingivitis · Dental Plaque · Pharyngitis · Diabetes Mellitus, Type 2 · Onychomycosis, led by 7 companies.

Furthest: phase 4, since Feb 6, 201515 company-led studies, 4 open or runningNext primary completion: Dec 1, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmolive61 open or runningphase 4since Feb 6, 2015Jul 15, 2014Jan 2, 2028phase 4 · NCT07619729
Procter and Gamble20 open or runningphase 4since Sep 29, 2025Feb 28, 2012none ahead
Sanofi20 open or runningphase 3since May 27, 2008May 27, 2008none ahead
Valenta Pharm JSC22 open or runningphase 1since Feb 17, 2025Feb 17, 2025Dec 1, 2026phase 1 · NCT06859281
Angelini Pharma10 open or runningphase 1since Apr 27, 2018Apr 27, 2018none ahead
NanoBio10 open or runningphase 2since Mar 26, 2007Mar 26, 2007none ahead
Suzhou Neologics Bioscience11 open or runningphase 1since May 25, 2023May 25, 2023none ahead

Also a collaborator on its studies: Cross Research.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 26, 2007First study: phase 2 study in OnychomycosisNew to NanoBioNanoBio · NCT00453271 · 443 enrolled · United States, Canada
  2. May 27, 2008Sanofi's first study: phase 3 study in HealthyNew to SanofiSanofi · NCT00687037 · 30 enrolled · Brazil
  3. Aug 4, 2008Phase 3 study in HygieneSanofi · NCT00729599 · 31 enrolled · Brazil
  4. Feb 28, 2012Procter and Gamble's first study: no phase study in GingivitisNew to Procter and GambleProcter and Gamble · NCT01549587 · 746 enrolled · United States
  5. Jul 15, 2014Colgate Palmolive's first study: phase 3 study in Dental PlaqueNew to Colgate PalmoliveColgate Palmolive · NCT02193165 · 120 enrolled · Puerto Rico
  6. Feb 6, 20152 phase 4 studies in Dental PlaqueColgate Palmolive · NCT02366689, NCT02360995
  7. Apr 27, 2018Angelini Pharma's first study: phase 1 study in HealthyNew to Angelini PharmaAngelini Pharma · NCT03706781 · 26 enrolled · Switzerland
  8. May 25, 2023Suzhou Neologics Bioscience's first study: phase 1 study in Advanced Solid TumorNew to Suzhou Neologics BioscienceSuzhou Neologics Bioscience · NCT05924906 · 30 planned
  9. Jan 7, 2025Phase 3 study in GingivitisColgate Palmolive · NCT06770114 · 80 enrolled · Italy
  10. Feb 17, 2025Valenta Pharm JSC's first studies: 2 phase 1 studies in PharyngitisNew to Valenta Pharm JSCValenta Pharm JSC · NCT06859281, NCT06857890
  11. Sep 29, 2025Phase 4 study in GingivitisProcter and Gamble · NCT07211061 · 69 enrolled · United States
  12. Nov 24, 2025Phase 3 study in GingivitisColgate Palmolive · NCT07263698 · 80 enrolled · Italy
  13. May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729 · 10,000 planned · United States

Ahead

  1. Dec 1, 2026Primary completion: phase 1 study in PharyngitisValenta Pharm JSC · NCT06859281
  2. Dec 1, 2026Primary completion: phase 1 study in PharyngitisValenta Pharm JSC · NCT06857890
  3. Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2Colgate Palmolive · NCT07619729

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 15 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07619729Diabetes Mellitus, Type 2 · United States4By invitationColgate PalmoliveJan 2, 202810,000
NCT07263698Gingivitis · Italy3CompletedColgate PalmoliveFeb 27, 202680
NCT07211061Gingivitis · United States4CompletedProcter and GambleNov 10, 201169
NCT06859281Pharyngitis · Russia1RecruitingValenta Pharm JSCDec 1, 202624
NCT06857890Pharyngitis · Russia1RecruitingValenta Pharm JSCDec 1, 202624
NCT06770114Gingivitis · Italy3CompletedColgate PalmoliveMay 9, 202280
NCT05924906Advanced Solid Tumor1Not yet recruitingSuzhou Neologics BioscienceApr 202630
NCT03706781Healthy · Switzerland1CompletedAngelini PharmaDec 18, 201726
NCT02366689Dental Plaque · United States4CompletedColgate PalmoliveDec 2014179
NCT02360995Dental Plaque · United States4CompletedColgate PalmoliveAug 2014129
NCT02193165Dental Plaque · Puerto Rico3CompletedColgate PalmoliveAug 2014120
NCT01549587Gingivitis · United States–CompletedProcter and GambleFeb 2014746
NCT00729599Hygiene · Brazil3CompletedSanofiAug 200831
NCT00687037Healthy · Brazil3CompletedSanofiFeb 200830
NCT00453271Onychomycosis · United States, Canada2CompletedNanoBioOct 2008443

How it is read

Names in the registry

  • “Cetylpyridinium chloride”, 2 entries
  • “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash”, 1 entry
  • “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
  • “Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash”, 1 entry
  • “Cetylpyridinium Chloride (CPC)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.